John P Kirwan1, Ali Aminian2, Sangeeta R Kashyap1, Bartolome Burguera3, Stacy A Brethauer4, Philip R Schauer4. 1. Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, OH. 2. Bariatric and Metabolic Institute, Cleveland Clinic, Cleveland, OH aminiaa@ccf.org. 3. Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, OH Bariatric and Metabolic Institute, Cleveland Clinic, Cleveland, OH. 4. Bariatric and Metabolic Institute, Cleveland Clinic, Cleveland, OH.
Abstract
OBJECTIVE: There is a paucity of data on the impact of bariatric surgery in type 1 diabetes (T1D). The aim of this review was to quantify the overall effects of bariatric surgery in obese patients with T1D. METHODS: We searched PubMed, Scopus, ISI Web of Knowledge, and Google Scholar from their inception to December 2015 to identify all relevant studies of bariatric surgery in adult obese patients with T1D. RESULTS: The review included 17 studies with 107 individuals, including 10 case series and 7 case reports. Overall, the dominant procedure was gastric bypass (n = 70; 65%). All studies reported a significant reduction in excess weight. A significant reduction in weight-adjusted daily insulin requirements was shown in all case series except one. Pooled mean ± SD of pre- and postoperative glycated hemoglobin (HbA1c) for the entire cohort with available data (n = 96) was 8.4 ± 1.3% and 7.9 ± 1.1%, respectively (P = 0.01). In addition to common postoperative complications, profound glycemic changes (diabetic ketoacidosis and hypoglycemia) and gastrointestinal dysmotility symptoms (prolonged ileus and acute gastric remnant dilation) have been reported. No surgical mortality was reported. CONCLUSIONS: Bariatric surgery leads to significant weight loss in severely obese patients with T1D and results in a significant improvement in insulin requirements and glycemic status. The favorable metabolic effects of bariatric surgery may facilitate medical management of and cardiovascular risk reduction in T1D in the setting of severe obesity. Diabetic ketoacidosis and hypoglycemia are potentially serious complications. Short-term results of bariatric surgery in patients with T1D are encouraging, but larger and longer-term studies are needed.
OBJECTIVE: There is a paucity of data on the impact of bariatric surgery in type 1 diabetes (T1D). The aim of this review was to quantify the overall effects of bariatric surgery in obesepatients with T1D. METHODS: We searched PubMed, Scopus, ISI Web of Knowledge, and Google Scholar from their inception to December 2015 to identify all relevant studies of bariatric surgery in adult obesepatients with T1D. RESULTS: The review included 17 studies with 107 individuals, including 10 case series and 7 case reports. Overall, the dominant procedure was gastric bypass (n = 70; 65%). All studies reported a significant reduction in excess weight. A significant reduction in weight-adjusted daily insulin requirements was shown in all case series except one. Pooled mean ± SD of pre- and postoperative glycated hemoglobin (HbA1c) for the entire cohort with available data (n = 96) was 8.4 ± 1.3% and 7.9 ± 1.1%, respectively (P = 0.01). In addition to common postoperative complications, profound glycemic changes (diabetic ketoacidosis and hypoglycemia) and gastrointestinal dysmotility symptoms (prolonged ileus and acute gastric remnant dilation) have been reported. No surgical mortality was reported. CONCLUSIONS: Bariatric surgery leads to significant weight loss in severely obesepatients with T1D and results in a significant improvement in insulin requirements and glycemic status. The favorable metabolic effects of bariatric surgery may facilitate medical management of and cardiovascular risk reduction in T1D in the setting of severe obesity. Diabetic ketoacidosis and hypoglycemia are potentially serious complications. Short-term results of bariatric surgery in patients with T1D are encouraging, but larger and longer-term studies are needed.
Authors: Soo Hwa Han; Stephen White; Kevin Patel; Erik Dutson; Carlos Gracia; Amir Mehran Journal: Surg Obes Relat Dis Date: 2006-09-18 Impact factor: 4.734
Authors: Andreas Lindqvist; Peter Spégel; Mikael Ekelund; Eliana Garcia Vaz; Stefan Pierzynowski; Maria F Gomez; Hindrik Mulder; Jan Hedenbro; Leif Groop; Nils Wierup Journal: Diabetes Date: 2014-01-31 Impact factor: 9.461
Authors: Paweł Ziemiański; Wojciech Lisik; Rafał J Marszałek; Tomasz Cieciura; Justyna Domienik-Karłowicz; Janusz Trzebicki; Tomasz Gryczewski; Zbigniew Wierzbicki; Maciej Kosieradzki; Magdalena Durlik; Piotr Pruszczyk; Andrzej Chmura Journal: Ann Transplant Date: 2014-12-08 Impact factor: 1.530
Authors: Ali Aminian; Christopher R Daigle; Héctor Romero-Talamás; Sangeeta R Kashyap; John P Kirwan; Stacy A Brethauer; Philip R Schauer Journal: Surg Obes Relat Dis Date: 2014-01-29 Impact factor: 4.734
Authors: Nuria Vilarrasa; Miguel Angel Rubio; Inka Miñambres; Lillian Flores; Assumpta Caixàs; Andrea Ciudin; Marta Bueno; Pedro Pablo García-Luna; María D Ballesteros-Pomar; Marisol Ruiz-Adana; Albert Lecube Journal: Obes Surg Date: 2017-04 Impact factor: 4.129
Authors: Hannes Götz Kenngott; Felix Nickel; Philipp Anthony Wise; Felix Wagner; Adrian Theophil Billeter; Johanna Nattenmüller; Diana Nabers; Klaus Maier-Hein; Hans-Ulrich Kauczor; Lars Fischer; Beat Peter Müller-Stich Journal: Obes Surg Date: 2019-12 Impact factor: 4.129
Authors: Roman Vangoitsenhoven; Rickesha Wilson; Gautam Sharma; Suriya Punchai; Ricard Corcelles; Dvir Froylich; Anny Mulya; Philip R Schauer; Stacy A Brethauer; John P Kirwan; Naseer Sangwan; J Mark Brown; Ali Aminian Journal: Surg Endosc Date: 2020-06-30 Impact factor: 4.584